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Abstract. Methionine adenosyltransferase is the enzyme 
that catalyses the synthesis of S-adenosylmethionine. In 
mammals three isoenzymes have been purified, two of 
which, MAT III and I, are products of the same gene 
MAT1A, but differ in their kinetic constants and 
oligomerization state. Changes in activity and MAT I/III 
ratio have been detected in animal models and in human 
alcohol liver cirrhosis, leading to an increasing interest in 
the mechanisms that control the protein association state. 
In this line, data demonstrating the importance of 
sulfhydryl groups on the activity and oligomerization of 
the protein have been obtained. These results along with 
knowledge of the crystal structure of MAT I and the 
establishment of an overall-folding pathway allow an 
integrated view for MAT behaviour. 
 
Introduction 
S-adenosylmethionine (SAM) was identified in 
1953 and since then the number of reactions in which it 
has been shown to be involved is constantly increasing 
(1). This compound serves as donor for different types of 
reactions in which distinct parts of the molecule are 
supplied. Those are: a) methyl groups for 
transmethylation reactions (2); b) propylamino groups, 
after SAM decarboxylation, for polyamine synthesis (3); 
c) 5’-deoxyadenosyl radicals for reactions catalysed by 
SAM radical proteins (4); d) the ribosyl moiety for 
queuosine synthesis (5); and, e) the carboxylic carbon to 
lipophilic acceptors (6). In fact, it has been calculated 
that SAM participates in as many reactions as ATP, but 
in contrast, there is only one for its synthesis that 
catalysed by methionine adenosyltransferases (MAT)(3). 
These enzymes are a family of cytosolic proteins that 
have been exceptionally well conserved during evolution. 
They use methionine and ATP in a peculiar reaction that 
renders SAM, pyrophosphate and inorganic phosphate. In 
mammals, three isoenzymes have been characterised and 
named according to its order of elution from phenyl 
Sepharose columns. MAT II is ubiquitous and 
heterotetrameric, whereas MAT III and I are homo-
oligomers expressed in liver and pancreas (7). Their main 
difference is the affinity for methionine, being MAT II 
the isoenzyme with the lowest Km (3). MAT III has been 
shown to be 10-fold less active than MAT I under 
physiological concentrations of the amino acid (60 µM). 
Other properties of MAT III are its activation by 
dimethyl sulfoxide (DMSO) and its high hydrophobicity, 
characteristics that are used for purification (8).  
A number of experiments have focused attention 
on the role of cysteine residues in the control of the 
activity and the association state of MAT I/III. In fact, 
neither the number of such amino acids (10 for the rat 
liver subunit), nor their location in the sequence is 
constant, but there are some characteristic positions of 
the liver isoenzyme (C61, C121) (9). Taking advantage 
of the presence of such residues, MAT I has been 
purified using thiopropyl Sepharose chromatography. 
Elution with reduced glutathione (GSH) produces a 
change in its kinetics increasing the affinity for 
methionine. In addition, its electrophoretic mobility in 
SDS-PAGE gels is also modified. Glutathione has been 
shown to exert several effects on MAT I/III depending on 
its oxidation state. Thus, both isoforms are inhibited by 
oxidised glutathione (GSSG), inactivation that leads to 
dissociation and can be modulated by GSH (10). The 
importance of cysteine residues has been further 
highlighted by their change to serine (11). Such 
mutations induce alterations in the MAT I/III ratio as 
compared to the wild-type enzyme, being especially 
important among cysteines comprised between C35 and 
C105 in the protein sequence. Moreover, the C69S 
mutant appears mostly as dimers. N-ethylmaleimide 
(NEM) modification of two sulfhydryl groups per subunit 
lead to enzyme inhibition and dissociation of the tetramer 
to render an inactive dimer (12). Modification using 
nitric oxide (NO) donors also produces enzyme 
inactivation, which is not observed in the C121S mutant, 
suggesting that this residue is the target for NO 
modification of MAT (13,14). 
  MAT I crystal structure. In order to obtain the 
amount of homogeneous protein needed for structural 
studies it was necessary to overexpress MAT in a 
heterologous system such as E. coli (15). Most of the 
protein was found in inclusion bodies, whereas a small 
amount appeared soluble. Purification from bacterial 
cytosol was precluded due to the presence of E. coli 
MAT (cMAT), and hence two refolding systems from 
inclusion bodies were developed in our laboratory 
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(scheme 1) (16). MAT forms obtained in the presence of 
DTT or GSH/GSSG buffers were fully characterised and 
shown to present analogous kinetics to rat liver purified 
MAT. Small differences were related to the number of 
free-SH groups detected and the presence of the protein 
in concentration dependent equilibrium (DTT-refolded), 
characteristics that were exploited in other experiments 
as shown below (17).  
The crystal structure of the tetramer (figure 1A) 
was obtained using DTT-refolded MAT at 2.7 Å 
resolution, and was shown to belong to the P4122 space 
group with 60% solvent content in the cell (18). The 
asymmetric unit contains a dimer with two subunits 
related by local two-fold symmetry. Two active sites per 
dimer involving residues from both subunits were 
identified. The tetramer structure was generated by two-
fold crystallographic symmetry. Contrary to what was 
observed for cMAT only a tetragonal crystal form was 
observed either at 0 or 20ºC (18,19).  
 The monomer (figure 1B) consists of three 
domains related by pseudo three-fold symmetry. The N-
terminal domain comprises amino acids 17-28 and 146-
254, the central domain includes residues 29-116 and 
255-289, and finally the C-terminal domain consists of 
amino acids 129-145 and 290-396. Superposition of the 
two known MAT structures, those for E. coli and rat 
liver, revealed a slight difference in the orientation of the 
domains in the monomer, the C-terminal domain of MAT 
I being twisted by 5.5º with respect to the bacterial 
enzyme.  
Moreover, the organisation of the subunits in 
cMAT is also different leading to a more open active site 
for the rat liver enzyme. Interactions between monomers 
can be defined as a flat hydrophobic surface between β-
sheets of both subunits in the dimer. In addition, a few 
polar interactions relating equivalent loops of both 
monomers are also observed, as well as the presence of a 
structural K+ ion. On the other hand, the contact surface 
between dimers is defined only by a few polar 
interactions.  
As for the cysteine residues proved to be of 
extraordinary importance in MAT oligomerization and 
activity, the five involved in alterations in the 
tetramer/dimer ratio as deduced from site-directed 
mutagenesis studies (C35, C57, C61, C69 and C105), are 
located in the central domain (figure 1B). Due to the fact 
that the interface between dimers is made only by this 
domain it can be deduced that these residues play a role 
in the stabilisation of the tetramer structure. Folding of 
the chain places only two cysteines in a situation such as 
to make a disulphide bond (C35 and C61), whereas 
sulfhydryls of C57 and C69 are oriented in opposite 
directions. Looking at the structure it can be deduced that 
only a local reorganisation of the main chain could allow 
the production of this second disulphide bond. C69 has 
been shown in site-directed mutagenesis studies to be 
crucial in dimer association, thus suggesting its 
involvement in an essential bond (18,20). The structure 
revealed that no such a crucial bond implicating C69 
exists, but changes in C69S activity and association state 
upon refolding have been observed, and hence a role in 
early steps on protein folding may explain its behaviour 
(17). 
Synthetic reaction catalysed by MAT. This 
enzyme catalyses an unusual reaction that takes place in 
two sequential steps, comprising SAM production and 
tripolyphosphate hydrolysis before product release (1). In 
the first step, a direct attack of the sulfur atom of 
methionine to the C5’ position of ATP occurs in a SN2 
reaction, which cleaves the triphosphate chain of ATP. In 
the next step, this tripolyphosphate is hydrolysed to 
render pyrophosphate and inorganic phosphate, this last 
one derived from the Pγ of the ATP molecule. Divalent 
cations (Mg2+) are needed for activity, and presence of 
certain monovalent cations, such as K+, activates the 
reaction (3,21,22).  
Identification of the ATP binding site has been 
the subject of several studies, in a first place 
photoaffinity labelling of rat liver MAT allowed the 
identification of a P-loop for triphosphate binding 
(peptide 267-286) (23). Later cMAT crystallisation in the 
presence of ADP and BrADP showed extensive 
interaction between the triphosphate moiety and the 
enzyme, whereas ribose and adenine binding was 
reduced to a few interactions (24).  
MAT I crystals were obtained using LcisAMB 
(L-2-amino-4-metoxy-cis-but-3-enoic acid), a methionine 
analogue inhibitor of the enzyme (18). The use of this 
compound allowed localisation of the amino acid binding 
site stacked against the aromatic ring of F251 (figure 
1C). The carboxylate of the inhibitor was coordinated to 
a Mg2+ ion linked to D180, whereas the other oxygen of 
the carbonyl forms a hydrogen bond with H30. A second 
Mg2+ is bound to D135*, and coordinates a phosphate 
bound to K182, that coordinates Pβ in cMAT-ATP. 
Amino acids D180, K182 and Q184 are located in a 
chain of the N-terminal β-sheet, a fact that fixed their 
positions. On the other hand, H30 is linked through a 
hydrogen bond to D32 that participates in a polar 
interaction network in the core loop. As for F251, this 
residue is located at the initial position of the F251-A260 
loop with its side-chain exposed to the solvent. This loop 
is mobile and connects the N-terminal and central 
domains, its sequence being highly conserved. The 
presence of the GGPXG motif should give a high degree 
of flexibility to the peptide chain. Crystals obtained using 
other methionine analogues, such as AEP ((2S,4S)-
amino-4,5-epoxipentanoic acid) show the same pattern of 
interactions as LcisAMB (25). The role of the residues 
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identified in methionine binding has been further 
explored by site-directed mutagenesis. None of the 
mutants prepared for D180, K182 and F251 was able to 
synthesise SAM, but all showed ATP binding and kept 
tripolyphosphatase activity (18).  
In order to get insight the catalytic mechanism 
ternary complexes were also prepared and analysed (25). 
Difference Fourier electron density maps of MAT I-Met-
ATP crystals allowed clear identification of methionine 
and ATP in the active site groove, as well as additional 
electron density compatible with the presence of a SAM 
molecule. Thus, it can be deduced that partial synthesis 
occurred, and this fact allowed localisation of SAM in a 
different orientation than ATP. The other ternary 
complexes explored, MAT I-AEP-ATP and MAT I-
LcisAMB-ATP showed electron density in the ATP site. 
The difference arises in the second of these complexes, 
where only ADP, in an orientation similar to that 
observed for SAM, seems to be present. Ternary 
complexes (figure 1D) show the amino group of N6-
adenine interacting with E71* (*indicates a residue 
belonging to the second subunit of the dimer), whereas 
N3-adenine is linked through a hydrogen bond to K290. 
In this complex, the strongest interactions are established 
by Pγ with H30 and E24 through Mg2, and with K182, 
K266 and D180 through Mgm (25). Methionine and ATP 
in these complexes present strong interactions. In fact, 
the amino and carboxylate groups of the amino acid 
interact with Pβ, and through the Mgm position with Pγ of 
ATP, respectively. However, C5’-ATP and S-methionine 
are located at 9 Å, a distance considered too large for a 
nucleophilic attack to occur. 
The mechanism for the reaction as deduced from 
the available data (figure 1E) would be: a) MAT I-Met-
ATP, shows the initial position of the substrates that 
could come closer by a simple torsion of the triphosphate 
chain keeping the position for Pγ; b) this torsion places Pα 
in a new position (P3), keeping its interaction with K182, 
whereas Mg3 continues located between S-metionine and 
05’-ATP; c) F251 besides orienting the lateral chain of 
metionine, could have a role in stabilisation of the 
positive charge produced in the transition state, through a 
cation π interaction; d) this movement locates ribose and 
adenine rings of ATP in an intermediate orientation 
simulating the SAM site; e) the flexible active-site loop 
could be involved in this conformational change of ATP; 
f) after SAM production the tripolyphosphate position 
can be modelled between those defined initially as P1 
and P2; g) such an orientation suggests a crucial role for 
Mg2 and K266 in tripolyphosphate hydrolysis. 
Overall MAT I folding pathway. The folding 
pathway was initially studied using the DTT-refolded 
MAT (26). Difficulties arise from the fact that this 
procedure renders a protein in a concentration-dependent 
equilibrium, and hence experiments were performed at 
<0.2 mg/ml, in order to ensure that the dimer was the 
main component. Urea-unfolding experiments were 
shown to be reversible, but in order to obtain maximum 
recovery of activity a two-step refolding procedure that 
populates the 2M urea intermediate is necessary. The 
presence of a monomeric intermediate during MAT III 
urea unfolding was revealed by gel filtration 
chromatography and sedimentation velocity experiments 
(scheme 2). Moreover, biphasic curves, with plateaus 
between 1-2 M of the denaturant were observed in 
tryptophan fluorescence experiments, as well as by 
circular dichroism. Unfolding followed by activity 
showed a rapid inactivation of the protein that seems to 
precede dissociation of the dimer. ANS studies revealed 
that even when the intermediate state binds the dye, this 
binding is lower than that shown by MAT III, thus 
suggesting the exposure of a smaller hydrophobic surface 
for the intermediate. This monomeric intermediate 
preserves 70% of the secondary structure of MAT III, 
and possesses some of the characteristics of a molten 
globule. All these data allowed calculation of the free 
energy of folding for the dimer that is 65.69 kJ/mol, half 
of this ΔG(H2O) value derived from monomer 
association. Kinetic experiments showed later the 
presence of another intermediate between the equilibrium 
monomeric intermediate and the native dimer (scheme 
2)(27). This second intermediate is supposed to be also 
monomeric, even when the association state of this short-
lived specie has not been determined.  
Dissociation of MAT I to MAT III was followed 
using ANS-modified protein, and for that purpose the 
modification reaction was performed at high protein 
concentrations (17). Using this modified MAT I kinetics 
of ANS fluorescence were obtained upon dilution to 
protein concentrations were only the dimer can be 
observed (50 µg/ml). Analysis of the results obtained 
allowed the identification of a new kinetic intermediate. 
Again, it was not possible to characterise the association 
state of this short-lived specie, but it is attractive to 
presume it to be a dimer that has gone through slight 
conformational changes to render the dimer in the 
tetramer (scheme 2). The fact that the ANS fluorescence 
intensity for the tetramer is double than that shown by the 
dimer suggests that this modification takes place in an 
area not related to association, but close by since 
dissociation can be followed using this technique. The 
ANS binding site has been identified as P358-G359 and 
the sequence 131VGA133 that was located at the start limit 
of the flexible loop to the active site (27). Taken together 
all these data we can suggest that the changes that lead to 
the kinetic intermediate should involve areas related to 
the active site, thus explaining the affinity differences 
observed between MAT I ad III. The reversibility of the 
association process allowed the calculation of the 
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ΔG(H2O) that was found to be –29.24 kJ/mol. Thus, the 
free energy change for the overall folding process from 
the unfolded monomer to render the native tetramer is 
102.14 kJ/mol. 
Thermal denaturation of MAT has also been 
studied using activity and intrinsic fluorescence 
measurements along with two-dimensional infrared (IR) 
spectroscopy (28). The increase in temperature induced 
irreversible changes with a Tm between 47-51ºC. Three 
regions can be distinguished in the profile: 1) 20-37ºC, 
with full enzymatic activity, 2) 37-55ºC, where changes 
in fluorescence and IR are observed, as well as activity 
loss; 3) >50ºC, a region with no activity and where no 
further spectroscopic changes occur. According to the 
synchronous and asynchronous maps, the first secondary 
structure elements starting to unfold are α-helix and β-
turns that are more solvent exposed. This step is followed 
by exposure of hydrophobic residues, intermolecular 
hydrogen bonds, and final aggregation. These 
phenomena in MAT can be due either to dimer 
dissociation and aggregation of monomers, or to a direct 
aggregation of unfolded dimers.  
Conservation of MAT sequence. A large number 
of eukaryotic and bacterial MAT sequences have been 
deposited in public databases during recent years, 
allowing their comparison (9). Thus, it has been shown 
that a 30% of the total number of MAT residues are 
identical in all species. Knowledge of structural data for 
cMAT and MAT I allowed a deeper analysis of these 
results. Hence, it is possible to identify 5 sequence blocks 
that define this family of proteins due to their high level 
of conservation. Block I (residues 20-47, according to rat 
liver) contains β-chain A1 and helix 1, as well as a motif 
involved in methionine binding, 29GHPDK33. Block II 
(residues 114-122 and 132-143) is located flanking the 
active-site flexible loop, and includes the ATP binding 
motif 132GAGDQG137. Block III (residues 177-189) is 
part of β-chain A2. Block IV (residues 246-300) includes 
the loop connecting N-and C-terminal domains, as well 
as a motif including 10 glycines (residues 254-281) 
preserved in all MATs. Block V (residues 372-389) 
contains the C-terminal and helix 9. All the amino acids 
known to participate in catalysis and substrate binding 
are in these perfectly conserved blocks.  
Analysis of the relationship between 
conservation and solvent accessibility has shown that the 
most conserved amino acids are highly represented 
among the less exposed residues. This distribution can 
reflect their role in catalysis, folding and stability of the 
enzyme. The fact that they establish the largest number 
of interactions between residues along with their 
hydrophobic character can be interpreted as indicative of 
a role in MAT folding nuclei, thus, comprising the main 
forces that stabilise the monomeric intermediate. In 
general, the study of enzyme families revealed how 
binding of the substrates and catalysis have been 
improved by the introduction of mutations, which in 
extreme cases lead to the acquisition of new functions 
(i.e. TIM barrels). As for MAT, no way to improve the 
function has been obtained, thus leading to the high 
conservation observed. 
The availability of a large number of sequences 
and a high conservation among them are characteristics 
that have been used for the selection of possible markers 
for molecular systematics (29). Thus, the possibility that 
MAT can be useful for such studies has been explored. In 
this case the knowledge of structural data for two distant 
species such as E. coli and Rattus norvegicus can also 
contribute to shade light on some aspects. Construction 
of a phylogenetic tree using MAT sequences revealed a 
common evolutionary origin for Eukaryota and Bacteria. 
Classification of species can be based on certain 
sequential and structural features, such as the number of 
amino acids in the loop connecting β-chains A2 and A3. 
Moreover, apparition of MAT I in vertebrates can be 
related to the development of a specialised organ, the 
liver. The few sequences available for Archaea served 
only to show a high divergence with Eukaryota and 
Bacteria. In fact, only residues related to substrate 
binding and catalysis are conserved (30).  
 Identification of a disulphide bond in MAT I/III. 
Neither NEM nor NO modification of the enzyme even 
after denaturation lead to complete labelling of all the 
sulfhydryl groups in rat liver purified MAT (20,31). No 
more than 8 cysteines react with these compounds, thus 
indicating the presence of two non-accessible 
sulfhydryls. Only when NEM modification was carried 
out in the presence of urea and DTT was it possible to 
label all the protein –SH groups, and hence suggesting 
the possibility of a disulphide bond within the structure. 
This disulphide could not be intersubunit, since SDS-
PAGE gels under non-reducing conditions showed bands 
with a mobility corresponding to that known for the 
monomer (48 kDa). As mentioned above, only elution 
from thiopropyl Sepharose columns under reducing 
conditions changed this pattern to 43 kDa, a value closer 
to that expected for the monomer (10). In addition, the 
mechanism shown by inhibition of MAT in redox buffers 
and its oxidation constant, calculated either in the 
absence or presence of thioltransferases, suggests the 
production of an intramolecular disulphide in this protein 
(10,32).  
 In order to clarify this point, purified rat liver 
MAT I and III were denatured with urea in the presence 
or absence of DTT and modified with NEM (scheme 3). 
After proteolysis and peptide mapping, peaks changing 
their mobility in either condition were isolated and 
further purified by HPLC. One of them eluted as two 
differentiated entities in a new gradient. Each of the 
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repurified peaks was then divided in several aliquots that 
were further analysed. Aliquots of the peaks from urea 
plus DTT treated samples were subjected to: proteolysis 
using endoproteinase Glu-C, amino acid analysis, and N-
terminal sequencing. In parallel, aliquots of peaks from 
urea treated proteins were subjected to the above 
mentioned procedures and to incubation with DTT. The 
results obtained indicated that one of the purified peaks 
contained a peptide with one cysteine linked to another 
containing two such residues. These peptides were 
identified as those containing C35 and another including 
C57 and C61. Thus, a disulphide bridge C35-C57 or 
C35-C61 exists. Identification of the residues involved 
was achieved by analysis of the results obtained by 
endoproteinase Glu-C digestion and N-terminal 
sequencing of that fraction. Only one labelled peak with 
a N-terminal sequence corresponding to the peptide 
containing C57 can be obtained, and hence the disulphide 
present in MAT I and III was established as that linking 
C35 and C61.  
 Cysteine 61 was found to be typical of hepatic 
MAT, whereas C35 appears in all the cloned proteins of 
the family, suggesting that the presence of a new, and 
characteristic sulfhydryl may be related to the 
oligomerization peculiarities shown by this isoenzyme. 
Moreover, production of disulphide bonds is highly 
dependent on the conformation of the protein, and on the 
local concentration of sulfhydryls during folding. This 
fact may allow the presence of such bonds even in a 
highly reducing environment as the cellular cytosol (33). 
The availability of the crystal structure of the protein 
further confirmed this identification and aided in the 
interpretation of its role in the protein.   
Role of the C35-C61 disulphide in rat liver MAT. 
As mentioned before, the five cysteine residues shown by 
site-directed mutagenesis to be involved in alterations in 
the tetramer/dimer ratio are located in the central domain 
(11,18). Moreover, concentration-dependent equilibrium 
for MAT forms has been shown in DTT-refolded systems 
and E.coli overexpressed rat liver MAT, where the 10 
sulfhydryl groups of the subunit are free. On the other 
hand, no such equilibrium has been observed in the rat 
liver purified MAT I and III isoenzymes nor in the 
GSH/GSSG-refolded MAT forms, where only 8 of the 
subunit –SH groups are accessible to chemical 
modification (16,17). Thus, the question arises as if the 
presence of a disulphide bond could be responsible for 
the stabilisation of the oligomeric forms. In order to 
analyse this possibility we have used wild-type MAT 
refolded form inclusion bodies using either DTT or 
GSH/GSSG buffers, as well as cysteine to serine mutants 
for C35, C57, C61 and C69. The concentration-
dependent equilibrium in all the cases was analysed using 
analytical phenyl Sepharose and large-zone gel filtration 
chromatographies (LZFGC). Isolation of the tetrameric 
forms was obtained by hydrophobic chromatography, its 
behaviour being further studied by dilution and reloading 
on phenyl Sepharose columns in order to test for the 
presence of dimers. The results obtained indicate that 
MAT I forms derived from wild-type, C57S and C69S 
when refolded using GSH/GSSG show stable tetramers, 
whereas those from C35S and C61 lost this characteristic. 
Calculation of dissociation constants was performed for 
wild-type, C35S and C61S using LZGFC in a protein 
range of 0.05-5 mg/ml. The Kd values obtained are all in 
the 105 M-1 range, as expected for a protein undergoing a 
concentration-dependent equilibrium. These Kd values 
were used to obtain the weight-average partition 
coefficient and the dimer fraction that later allowed 
calculation of the free energy of dimer/tetramer 
association (-29.24 kJ/mol). 
In parallel, chemical modification (EP, 
ethylpyridylation; VP, vynilpyridylation; or REP, 
reduction plus ethylpyridylation) of the purified MAT 
forms derived from wild-type, C35S and C61S followed 
by mass spectrometry were carried out (scheme 4). 
Analysis of the mass data allowed calculation of the free 
–SH groups in each case. The presence of 10 free –SH 
for DTT-refolded and reduced GSH/GSSG-refolded 
wild-type was shown, whereas this number was reduced 
to 8 such groups in GSH/GSSG-refolded wild-type and to 
9 in C35S and C61S mutants refolded with either of the 
systems.  Proteolysis of the modified wild-type proteins 
in the presence or absence of DTT followed by mass 
spectrometry allowed identification of the cysteines 
involved in the disulphide bond produced by GSH/GSSG 
refolding that is C35-C61. Hence, all the data indicate 
that the presence of such a disulphide blocks association 
of MAT III to MAT I. Moreover, identification of this 
disulphide in rat liver purified dimers and tetramers as 
well as that of an intermediate in the dimer/tetramer 
association step, suggests that this post-translational 
modification takes place at the dimer level. We propose 
that production of the C35-C61 bond in the dimer leads 
to stable MAT III that is not able to associate. However, 
if this dimer undergoes the small changes that make the 
difference with the putative dimeric intermediate, the 
disulphide bond made in this new form would only 
evolve associating to the tetramer (scheme 5).  
Conclusion. MAT I is a dimer of dimers in which 
sites for methionine and ATP binding have been 
identified. Folding of MAT I/III occurs through several 
intermediates, the final oligomeric forms being 
determined by the step at which the native C35-C61 
disulphide is established. In addition, structural studies 
identified substrates and products adopting intermediate 
positions, these data allowing development of a putative 
catalytic mechanism.  
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Legends to the figures: 
 
Figure 1. MAT I structure. The figure shows MAT I structure and the active site. A view of the tetramer with the 
methionine analogue L-cisAMB appears in panel A. Panel B shows the monomer indicating the position of the visible 
cysteine residues. Panel C is a view of the active site including the methionine analogue AEP and the flexible loop 
containing F251. Panel D shows atomic interactions of methionine and ATP in the active site with magnesium and 
phosphate locations. Panel E, shows a superposition of the substrates and products in the active as observed in the 
different complexes obtained to date, and a hypothetical intermediate state. 
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